Kwality Pharmaceuticals Profit & Loss Annual

BSE: 539997 | NSE: KPL | ISIN: INE552U01010 | Sector: Biotechnology & Drugs

3,375.00 -155.45 (-4.40%)Updated : 14 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	405.44	308.10	267.48	222.38
Other Net	1.91	1.65	1.83	2.89
Total Adjustmentsto Net Income	0.00	-	-	0.00
Diluted Weighted Average Shares	1.04	1.04	1.04	1.04
Gain( Loss)on Saleof Assets	0.71	0.03	0.00	0.05
Depreciation/ Amortization	19.81	18.29	19.56	14.96
Operating Income	97.65	62.10	39.69	28.65
Net Income	67.35	39.85	23.80	19.37
Income Availableto Com Excl Extra Ord	67.35	39.85	23.80	19.37
Other Operating Expenses Total	0.00	0.03	-	50.86
Net Income Before Taxes	89.49	54.14	31.10	25.57
Minority Interest	0.00	0.04	0.18	0.09
Net Income After Taxes	67.35	39.80	23.62	19.28
Income Availableto Com Incl Extra Ord	67.35	39.85	23.80	19.37
Costof Revenue Total	285.13	205.86	170.40	110.07
Gross Profit	217.96	164.34	136.77	140.96
Interest Inc( Exp) Net- Non- Op Total	-10.78	-9.63	-10.42	-6.02
Unusual Expense( Income)	0.83	0.00	7.10	16.53
Diluted Net Income	67.35	39.85	23.80	19.37
Provisionfor Income Taxes	22.15	14.34	7.48	6.29
period Type	-	-	-	-
Net Income Before Extra Items	67.35	39.85	23.80	19.37
Total Revenue	503.08	370.20	307.17	251.03
period Length	12.00	12.00	12.00	12.00
Revenue	503.08	370.20	307.17	251.03
Selling/ General/ Admin Expenses Total	99.67	83.92	70.42	29.96
Diluted Normalized EPS	64.99	38.38	28.13	30.64
Diluted EPS Excluding Extra Ord Items	64.90	38.40	22.93	18.67